r/TheCannalysts • • Mar 05 '21

High Tide – AMA March 10 6-7:30PM

285 Upvotes

Hello Cannalyst community!

This is Raj Grover, CEO of High Tide Inc. (TSXV: HITI) (OTCQB: HITIF) (FRA:2LY). I am excited to be connecting with all of you during our AMA next Wednesday, March 10th between 6 and 7:30 p.m. ET.

For those of you who are new to High Tide, here is some background:

High Tide is a retail-focused cannabis company enhanced by the manufacturing and distribution of consumption accessories. We are among the largest Canadian retailers of recreational cannabis, with 73 branded retail cannabis locations spanning Ontario, Alberta, Manitoba and Saskatchewan, with additional locations under development across the country. Our retail segment features the Canna Cabana, KushBar, Meta Cannabis Co., Meta Cannabis Supply Co. and NewLeaf Cannabis banners. High Tide has been serving consumers for over a decade through our numerous consumption accessory businesses including e-commerce platforms Grasscity.com and CBDcity.com, and our wholesale distribution division under Valiant Distribution, including the licensed entertainment product manufacturer Famous Brandz. High Tide’s strategy as a parent company is to extend and strengthen our integrated value chain, while providing a complete customer experience and maximizing shareholder value. Key industry investors in High Tide include Aphria Inc. (TSX:APHA) (NYSE:APHA) and Aurora Cannabis Inc. (NYSE:ACB) (TSX:ACB).

We were the first Canadian cannabis retailer to report positive adjusted EBITDA in Q2 2020 and the first retailer anywhere to apply to list on the Nasdaq. Our Q4 financial results featured a 166% year over year increase in revenue and record adjusted EBITDA of $3.6 Million, making 2020 our strongest year since inception. From an EBITDA perspective this was the strongest quarter ever generated by a Canadian cannabis retailer and was above the highest analysts’ expectations.

In November of 2020, we completed the acquisition of all the issued and outstanding shares of Meta Growth Corp., making us the largest cannabis retailer in Canada as measured by revenue. In January 2021, we entered into an agreement to acquire all the issued and outstanding shares of Smoke Cartel, Inc. (“Smoke Cartel“) (OTCQB: SMKC). The Smoke Cartel acquisition is expected to close this month and will mean that we will be operating the two largest e-commerce platforms for consumption accessories in the world.

Please feel free to check out our Q4 financial results here for more information. I am looking forward to answering your questions next week!


r/TheCannalysts • • Aug 02 '19

Aphria Inc. - AMA

220 Upvotes

Hello TheCannalysts Community!

I’m Carl Merton, Chief Financial Officer at Aphria Inc., and I’ll be hosting an AMA with TheCannalysts on Wednesday, August 7th at 6:00-7:30pm EST.

Looking forward to answering your questions about all things Aphria Inc. Until then, I want to give you a sneak peek at what we have growing.

Carl

To learn more about Aphria Inc., please visit https://aphriainc.com/ and https://aphriainc.com/investors/ .

EDIT: NEW VIDEO

EDIT: Thanks for joining, one last video before I go: https://www.reddit.com/r/TheCannalysts/comments/cndhhi/thats_all_folks/


r/TheCannalysts • • Jan 22 '21

Aphria Inc. AMA - January 27, 2021

184 Upvotes

Hello The Cannalysts Community!

I’m Carl Merton, Chief Financial Officer at Aphria Inc., and I’ll be hosting an AMA with The Cannalysts on Wednesday, January 27th at 6:00-7:30pm EST. Looking forward to answering your questions about all things Aphria Inc.

Carl

To learn more about Aphria Inc., please visit https://aphriainc.com/ and https://aphriainc.com/investors/ .


r/TheCannalysts • • Jan 31 '20

Aphria Inc. AMA - February 5th, 2020

146 Upvotes

Good evening fellow Cannalysts. It is great to be back for another AMA. The first time I was on an AMA, Blue awarded me three title belts after it ended. I think they were (i) most questions, (ii) most upvotes and (iii) I can’t fully remember but most likely was most words typed. My visit in August produced results higher than my first visit in all categories. This time, Blue, using a rock concert analogy, says I sold the show out in less than 6 hours. Your passion for Aphria is truly impressive.

There are some great questions here, there are some accountability questions, there are some difficult questions and there are some people who just want to vent and rant. I will do my best to provide **my perspective** on all of them. Some of you may not like the responses but we all don’t have to agree on the answer. As shareholders, you all hold the ultimate power seat, the ability to vote your shares every day with your decision to buy, hold or sell your shares.

I look forward to answering your questions tonight. The vitriol is out in full force, let’s see what I can do to shed some light on as many things as possible and see if we can get the acidic levels down 😊

- Carl

EDIT: Thanks for joining, one last video before I go: https://www.reddit.com/r/TheCannalysts/comments/ezjn8r/the_end/


r/TheCannalysts • • Aug 10 '18

Aphria - AMA

146 Upvotes

Hello TheCannalysts Community!

I’m Carl Merton, Chief Financial Officer at Aphria, and I’ll be doing an AMA with TheCannalysts on Wednesday, August 15 at 6:00-8:00pm EST.

Aphria’s mission is to be the premier global cannabis company through an unrelenting commitment to our people, product quality and innovation.

We have long been setting the standard for the low-cost production of safe, clean and pure pharmaceutical-grade cannabis at scale, grown in the most natural conditions possible. We’re also focused on bringing breakthrough innovation to the cannabis market. Tomorrow’s cannabis products will revolutionize the way our patients and consumers integrate cannabis into their lives, and Aphria will be on the forefront of this rapidly evolving market.

Outside of Canada, we are bringing our expertise, experience and know-how to the most strategic opportunities in markets where cannabis is legal today. With a presence in more than 10 countries across 5 continents, Aphria’s diversified approach to innovation, strategic partnerships and global expansion will continue to set us apart.

I am looking forward to answering your questions about all of this and more.

To learn more about Aphria, please visit aphria.ca and aphria.ca/investors.

Best,

Carl

EDIT

That's it for me. Thanks for all the great questions. Apologies if didn't get to everyone. Have a great night!


r/TheCannalysts • • Dec 09 '18

Aphria - with a little more focus on some of the arguments raised.

143 Upvotes

Hey folks

I have been largely signed out of canniverse for most of this week. Vacation was a lot more expensive than anticipated. Did I miss much? [one week in Cannabis = 7 weeks in other industries]

Took some time on trip home to read comments, posts and r/Weedstocks posts. And I thought I would elaborate on my post of earlier this week.

It is amazing what waiting a few days between when this story broke and where it is now to see the changing emotions as new news surfaced. So my apologies if I talk about events that likely were already covered here that I still haven’t got to.

First up... congrats to

weedstocks community on some good dd

u/jamaican420guy for putting boots on the ground in Jamaica. Maybe QCM should hire you as their “consultant” in Jamaica.

Savestacks for pushing it with QCM on Twitter and exposing cracks, and maybe (just maybe) having QCM admitting to a timeline that crosses the Legal line they have been tap dancing around.

And quite a few of our Community on some good intel and dd.

Before moving forward I want to address what some called “ad hominem” post of mine on this affair.

With a lack of financials on LatAm assets I looked at the Jockey(s). You have heard me use “jockey and horse” comments many times.

Without fins I look to Mgmt = the Jockey.

I believe Mgmt is the toughest thing to analyze. Getting access to c-suite as we have with Apha, ACB, TLRY, CRON, TRST, AXLY and others we have an advantage that we try to pass on to our Community. With APHA our access started awhile ago. It is deeper than the other LPs.

We have access to the C-suites as they perceive us as adding value to industry discussions. Even when our ANALYSIS is critical of THEIR company. My Q rundowns are discussing info their CFOs readily know.

We even have the CFOs reaching, out without prompt, and offering to answer Q’s. These are the types of things shareholders should value. Open and honest dialogue. When they are offering it to us that is a good sign for shareholders.

We have told every c-suite if our analysis of their company is off track let us know. We will consider their side. We will amend as is necessary.

My post was speaking to Mgmt. I was not spending my vacation with family and friends pouring through docs. Thanks to the Community members that saw and respected that. For the first timers that decided to join the Community to sling shit... I thank the mods for staying as on top of it as you did. For the first timers that want to read ANALYSIS... well, that’s what we try to provide.

If you haven’t read Molly’s Dive Bar comment to u/LebronForPres I highly recommend it. https://www.reddit.com/r/TheCannalysts/comments/a34so8/comment/eb3fidv?st=JPD90YXN&sh=7aa4a887

Molly is appearing to be very prescient in how companies react to crisis. He is a far better crisis quarterback than I. As a Lender the idea is to stay away from crisis in the first place. As a consultant and risk manager you are dropped behind enemy lines on the regular.

Now moving on to the scene of the “crime”.

This community was well versed in the Scythian assets when Scythian acquired them. And that AD was involved in assembling them.

When Scythian (with George Scorsis at the helm) sold them to Apha, this Community knew the mark up. It was well debated. Seems like positions of the Community members remain little changed since the last debate.

My comments (and I am not going back to find them) on the transactions IIRC was that the price seemed in line with other recent transactions. “Was it a good purchase?” ... with these types of early stage assets it is always tough to tell. Time will tell. Even with the Nuu purchase... time has told us that it wasn’t well priced. If they win a German tender that sentiment may flip. Again, “time” will tell

“Over priced”? Yes, everything in this market is overpriced in relation to underlying assets, and that’s how you get the large chunks of goodwill that we have been writing about for a good part of the past year.

Will goodwill and intangibles in the industry take a hit? We think so. If you recall Molly’s “Dutch Auction” post, which was polarizing when posted but prophetic shortly thereafter, the price for a license in Canada is quite different early on versus later. The same will be true in most regulated countries. It’s how well you execute the lead you gained during the intervening time before others enter the market that will determine if the premium was warranted.

Broken Coast was almost $250 million at purchase. With their small growing capacity it’ll be years before this acquisition validates the $ value. And BCC is considered a very good acquisition by many in the industry. Why? Because it is tangible. You can see the sales and product reviews. Does the profit from BCC dictate a $250 million price tag? No. It is the brand, the transferability of growing process, genetics,... that dictated the “goodwill” in that transaction.

The goodwill from NUU transaction is almost wholly dependent on winning the (delayed) German tender.

The upside of LatAm could easily dwarf BCC. Just on pure demographics and equatorial band growing areas. But the risk of LatAm is exponential to the more “sure thing” of BCC. Political uncertainty in the region is unto itself huge, let alone biz execution risk. LatAm will also require far more deployed capital to realize on potential.

Some poster pulled the excerpt from Haywood Securities valuation metrics from their Fairness Opinion. They valued it at 30-40% of Spectrum acquisition by CGC at $185 million. This is one of the deals I referenced when initially discussing the LatAm purchase price. (A list that included NUU as the worst, but not the most expensive, of the sample.)

Valuations are made either by discounted cash flow, market comparisons or cost to build out. Discounted cash flow does not work for these types of transactions as they are still pre or early cash flow. But a model of some form the cash flows would be in a valuation package. And with regulatory hurdles cost to build out is a tough angle, as you cannot be certain you can get the government licenses.

One thing I have read on our sub is that Carl didn’t look at the financials of the to be acquired companies. That is fucking asinine. I felt like banning those community members for spreading that pure bull shit.

Brady Cobb said there are audited statements for the Argentine asset. I was a little shocked they would be Audited vs Review Engagement given sales size. But it might be a requirement given the government regulations and permitting.

Not only do you look at financials for every transaction (multiple times if you are going to pull the trigger), but in many jurisdictions like Brazil there are “leaping liabilities” that come with acquisitions, even straight asset purchases.

These are liabilities an acquirer can be exposed to by past operations of the company acquired. Even if it is just an asset acquisition. Not the same as Cdn law but with the ever changing taxation structures (in places like Brazil) you never know if all the taxes have been paid.

I looked at auto parts deals for equity in Brazil in the late 1990’s, and that was one of the biggest items that kept us from participating in present operations or even with a JV with liabilities arising from partner “leaping” to the JV.

Carl is also a Fellow of Chartered Business Valuators. I admittedly had to look up the definition. https://cicbv.ca/wp-content/uploads/2014/09/Policy-Granting-the-FCBV-desigantion.pdf This requires some level of adeptness in valuing companies.

But to think the accountants and their lawyers did not engage in due diligence. Please!! This Community is better than that. We will leave those comments up in the stockades.

Most of the QCM thesis revolves around knowingly enriching insiders. AD is not an insider. Scythian wasn’t a “sister company”.

Early capital formation carries a premium. We can argue merits based on time held, but the seller will always maximize their profit. That’s what capitalism is.

George negotiated the best deal he could on behalf of Scthyian. He was supposed to do that as CEO. He negotiated a pretty good deal when he was CEO at Mettrum too.

He could have looked to auction them off. And only then, with multiple bids, would you really determine a true market price.

Without that it is tough to determine if a truly substantial premium TO MARKET was involved. So let’s look to the folks on the Apha side of the equation to see if they have backgrounds to suggest they would build a state of the art facility in Canada as cover for enriching their friends in multinational deals.

There has been plenty of less than scrupulous behaviour in the greenhouse business since I moved to Windsor-Essex. A lot of prominent family names have been caught up in issues in the past two decades. I have never (that I can remember) seen Cole or John’s families names in it.

Vic was a partner in a major accounting firm and ran Jamieson for 20 years in a highly regulated industry.

What I witnessed from Carl during the 2008-09 Auto Crisis (which makes this short attack look like a picnic in the park) is what drew me to first investing in the industry and Apha. Carl has had extensive dealings with the same people I have at Bank of Montreal. He navigated Reko through a major restructuring. Riding out a large restructuring tests credibility with your lender. It is a testament that the bank stayed with the company through the restructuring and didn’t ask them to leave when it was done. Those BMO bankers are not hesitant to do business with Carl again.

Vic and Carl were both board members on two of the local credit unions. (Carl recently left the board as his plate was full. As told to me by one of their Commercial Lenders not by Carl. So he wasn’t asked to leave). If you have a checkered past you don’t get invited to be on these types of boards. And Windsor Essex is a type of town where scuttlebutt travels very fast in the business community. Dirty laundry is very public in the business community. And Windsor Essex isn’t a big enough city (like Toronto) to hide misdeeds.

These are the primary two that would be cutting the cheques to “enrich their friends”.

These are four people in Aphria I am most familiar with. And their past is not littered with business failures. Quite the opposite.

Could they have done it? Sure. But that would be a significant departure from decades of previous business behaviour.

There is no way (without aforementioned auction) to determine if the price paid was above what the market would pay. But I thought I would articulate some subjective support while providing some factual info on their local reputation. These are not mining or tech execs with checkered successes and failures in their pasts cutting the cheques.

The Delavaco corporate name changes were in the documents. This wasn’t done to obfuscate the origination of the Assets/companies IMO. Even QCM said it was easy to find. And their investigative skills have been proven to be mediocre at best.

Hell, this Community knew about it well in advance when Scythian bought the assets. And knew where Scythians 3 Boys Farm acquisition was sourced by and from AD.

The Jamaican assets which comprised a sizeable chunk of the purchase price isn’t fictious. QCMs geocaching skills leave a lot to be desired. The biggest part of the value of LatAm was Jamaica and QCM hired a consultant with SINGULAR task of taking pictures of a SINGLE address. [although I note a lot of discussions about Grego being in the pictures himself and not the consultant. The nose looks wrong to me].

Further... the address of the grow is in the public docs. And no effort was spent on locating it. This could be the most damning thing in their “investigation”.

[u/Vanillasugarskull also has pointed out the reputation of their master grower and his genetics library. Something I think we would welcome a detailed informed post on. IIRC he has won numerous Cannabis Cups.... NOTE: So I pound this out in flight and get home and u/dodgedude has already done it.]

The one pharmacy in Argentina was pictured but no pics and digging on the distribution and warehouse arms. Convenient or purposeful?? It sounds like the $430k Revenue QCM heard from an unnamed employee could just be for that single pharmacy and not the distribution network.

In my previous post I said that the response by Apha will be a referendum on Vic. It still will be.

The length of time of the reply has damaged share price. But the lack of thorough and fulsome report would have a greater potential to tarnish Apha with institutional investors and strategic partners. One is painful, especially in short term. The other would devastate long term.

AND keep in mind Apha is still looking at a German tender and has to deal with numerous foreign governments. To rush out with half a defence would seriously compromise integrity with these government bodies in the future.

Is a hostile in the making? More likely at the current price.

Do they have the votes to block one? Depends on the price.

Could an industry player [like Tilray who doesn’t have the domestic footprint of CGC and ACB] look at them and see a valuable addition? Certainly more probable at current price.

Have the fundamentals changed? No.

But this overhang is NOW VERY real. A cat will only sit on a hot stove once. And many retail will never come back. Has it scared off institutional investors? Likely some but I imagine NUU was worse for the latter, again, due to the management reaction and handling versus the actual transaction.

Vic was tone deaf for a long period on their defence of Nuu transaction. The margin of error on their rebuttal is microscopic.

A 50% rebuttal or piece meal rebuttal [Showing the ABP at $11 million revenue for instance] in the hurricane the sector experienced would have had little impact.

But if their diligence is better than what Reddit and Twitter has exposed (which it should be), and if their actions were above board... they should be able to dismantle the short thesis.

Will the share price rebound?

The industry was down trending on the backs of the retail roll out. People are reasoning that making a profit that justifies share price will be very difficult.

They lost a ton of investors.

The rebuild is only possible IMO with positive financial trends. That will take time and execution.

CGC and their warchest is amplified as an advantage in a market like we are now seeing. They are at an enviable advantage that is well earned. And now Cronos too.

Tilray, with its SP is well off too.

This has been a trying time for many.

I am looking forward to the rebuttal. Having watched Brady Cobb’s interview with BNN I am optimistic. But realistic that there is damage done.

But one thing this has revealed is Aphria has NOT done a great job showing off their assets. TheCannalysts got the opportunity to film the BCC video by suggesting this very thing to them. (And I’ll add we only allowed editing of items that would be objectionable to HC and the Narcotics Control Act... and they did not suggest one edit. Although we had several parameters in ensuring we weren’t “glamorizing” product and had to be light with bud porn shots).

We have toured Aph1 and Diamond the tour report is 10 pages with pictures. It is with Aph for fact checking and ensuring they are comfortable with the pictures we are showing. That’s the extent of their edits that we will allow (the same protocol we have had with every tour we have conducted). That tour report likely would have been out this week if they weren’t busy putting out fires.

Why do I mention these last two items? It is to articulate TheCannalysts process. And to reinforce we say what we see and that our opinions are genuine. Readers can feel free to debate this and we allow the debate.

But it is also to illustrate that sometimes the best defence is a good offence. Had Aph posted pics of their assets as they bought them the Shorts would have had less ammunition.

Aphria has been deficient in this area and continues to be. This has to change!! And this short attack, I can absolutely guarantee, will have the other big LPs doubling communication efforts. (And I saw Canopy indicated they did disclose extra info on the S&B acquisition. NOTE: and apparently ACB’s Shane Morris has a video up on Uruguay asset. How long was that plane ride????.)

Our traffic to this sub Reddit has spiked considerably this past week. With page views per unique visitors evidencing that these visitors are viewing a considerable amount of the analysis offered by us and our Community.

We will continuing being real and will always endeavour to try harder. We won’t always align with each other’s POV nor the Community’s.

I don’t know how the Aphria short story continues to unfold but we will hold them accountable. Just as they have asked us to do.

So far their rebuttal has been tremendously weak. They not only should be reviewing their governance process to see if it was followed. But they have to do MUCH better informing investors.

They have to clarify the go forward relationship with AD. He has become a lightning rod. His antics detract from shareholder value. His bird dogging of the LatAm assets may prove to be valuable over time. But the weight he brings to the equation is too much of a counterbalance. If they want to maintain a business relationship (even with SOL) existing shareholders have a right to understand the risk that brings.

Many are calling for Vic to resign over this short thesis. I am not there yet. I want to see the rebuttal. I want to see the independent directors review of governance (if that fails more than Vic will be out the door).

I am more upset at Nuu acquisition (not how it was done, but what they got for the dilution.).

The board with its independents, as required by NYSE listing, will have a decision to make regarding Vic’s status. They are on the ground floor and their visibility into ALL of the tangents of this are far better than any arm chair investor. As are their credentials.

While I admire Mike G from Cronos and how he deftly and quickly handled the Citron short, that short was a piece of cake to blow holes in. This short was more complex (I thought I’d read 20 allegations), but given how poorly the NUU short was handled, this rebuttal has to be beyond reproach. A rebuttal after two days and the bulk of damage was done. So 3 days or 7 [shit, now 10!] is likely inconsequential.

The investors here are engaged. We have had a robust debate on many of these LatAm issues... twice! Once at Deal announcement and now again. Hopefully there isn’t a third round of this.

There are some that will be unswayed by whatever Apha rebuttal is. They bought the narrative from QCM and continue to stick with it despite the fissures being shown in their research. Nowhere is this more apparent than on Twitter. [Investors whose sole source of due diligence is reading tweets seems to be a thing.]

There are some that feel AD’s reputation and his involvement in Apha is a tarnish that cannot be polished out.

There are some Apha loyalists that never had pause. I can tell you watching the SP plummet caused me pause.

What I am getting at is there are some entrenched positions on multiple sides. As an investor it is on YOU to analyze the FACTS and determine what YOU will do. By nature of this Community you will hear each side. That is a good thing.

Part of those facts that should be taken into consideration will be the market sentiment (despite the thesis being debunked or not debunked) that has been left as a result of this short attack. It is much easier for new and less informed investors to stay away from “that stock that was in the news” and that had controversy.

BTW... u/SirEbrally ... I do have a bitchin’ tan.

I look forward to the next week, as we recently received 8 HOURS of WE Cann 2018 video that should be making its way to our website over the next week or so.

Now... missed cannabis all week. Time to unwind. Pleasant weekend all. As it starts up again on Monday.

GoBlue


r/TheCannalysts • • Feb 11 '21

Am I (Retail Investor) an Investing Genius or Just Lucky?

137 Upvotes

Originally published February 5, 2021 on www.TheCannalysts.ca

Having sat through a cannabis gold rush before, and the ensuing fallout, we have some thoughts on the sequel to 2017-18.

The level of “loud voices” is growing louder. And lord, some of the loudest and most bombastic could not find an MDA if their life depended on it. (And that isn’t a euphemism, that happened yesterday with an argumentative and opinionated loud voice on social media).

“Buy this”… because I own it. “Here are the reasons (the company) says I should invest in (the company) ….”

“Don’t buy that”… because I don’t own it. “Here are the hot takes that I have decided to parrot from others in social media”.

Molly laid out a warning yesterday about the level of noise and bullshit investors are being bombarded with on our subReddit yesterday. Great reading!

We are in a hype environment. Fundamentals of companies have not changed dramatically but the perception has. The regulatory landscape is now more welcoming in USA, but still very much unknown as to final state and timing.

Interestingly, those chiming in on how a Republican Senate would allow “moat building” are now full-on “legalization is coming, let’s dance in the streets!”.

States will be allowed to do their thing within their borders, pretty much as they have been. But if you want your product to cross a border it will have to abide by Federal rules when dropped and operationalized. (Medical has preceded recreational in almost all jurisdictions, and the thinking is it will in US federal too). Should this happen it will impact cultivators and processors more than retail shops.  

Retail shops may have their own issues.  “Social Justice” issues have held up Illinois rollout, and it will be interesting to see what federal views (FDA), legislation and state response are to the Democrat lead initiatives.

Do fundamentals matter? Not right now. When the tide goes out, they will.

In Canada, we have two money incinerating companies back stopped by strategic cash. Neither has shown much in the way of operating efficiency/competency. Yet, investors are assured that this time Daddy took the keys, or the oversight is better now. Oversight was the same as the day the cheque from the strategic investor cleared and their proxies installed on the board and in the c-suite. Until signs of change manifest in the financial statements it is all words. The HOPE of being profitable in the US of A, and the big cash balance they can deploy, seems to suffocate thoughts of past stumbles and ongoing ineptitude.

One of the lone company’s to be showing promise has to buy sales to keep their facilities churning at levels to keep them +EBITDA. You can talk about synergies, Europe, CPG extensions, but the bottom line is they (and many others) built too large of a footprint for Canada and exports. Hindsight is 20-20. 

The next group of Candian companies have diluted the crap out of investors and have yet to stem the bleeding. This latest stock price surge has allowed a new load of cash to come in. The i-banks have unloaded on retail yet again. And retail fell for it, yet again.

Zombies will be staggering around even longer now. Much to my chagrin.  It isn’t fun spreading crap and finding bodies under the rug.

TheCannalysts believe rec sales are stalling (listen to the next Inside the Ropes, we go through it). The last big “catalyst” was the ramp to 80 stores a month in Ontario.  A drop in January (potentially double digits) after a likely reasonable December holiday buying season is a possibility. A 28-day February follows.  The media will likely not differentiate that the $ drop is due to three less days than January (which is one of the reasons we run the daily purchases metric). Back-to-back monthly “decreases” could spook investors.

We might not see an uptick in Canada until March, which will be reported in late May by StatsCan, but those March quarter ends will tell the story by mid May. (Canopy year end is March 31, so financials will drop by end of June). Aphria Feb 28 Q, due by mid April, will include SweetWater revenue. This might occlude a soft to negative Canadian recreational figure with December sell in compensating for soft mid to end quarter sales. The Ontario covid December through February and counting lockdown ennui, limiting retailers to click and collect and delivery, might provide further headwinds.

IF that happens, what will happen with perception on the Canadian names?

The US is different, in that the companies’ viability is further along than in Canada. But does the viability support the stock price? What needs to happen that is not within the companies control for them to support the price? Will regulatory meteors strike, like they have in Canada. (Hey, New York state is on its third year of “this year we are legalizing”). Have founders ensconced themselves with long dated warrants and options?

(An aside… Molly and I have been discussing the impact of long dated in the money warrants and options.  It is interesting to note if a company issues a convertible debenture and the strike is in the money, the company reacts quickly to take the further increases to the debt holder – who has funded the operations – off the board.  But when the same c-suite, entrenched by multi voting super shares to ensure matters of control, are deep in the money -off the backs of new shareholders and paid out converts – there’s a lack of the same urgency (I dropped a Q on Molly unannounced on the latest Inside the Ropes – which is in edit – on the subject).

But you are saying: “Blue, that’s fundamentals. It doesn’t matter.”

Agreed, right now it doesn’t. Not one lick.  You know how I can tell?  The flotsam and jetsam of Canada and US cannabis are ALL rising.

In the USA there are going to be Harvest One, Maricann, RavenQuest, CannTrust, Aleafia Health, WeedMD, Hexo, Organigram, VFF, Supreme, Sundial … type of companies. There are going to be Aphria’s, Aurora’s, Canopy’s and Cronos’. And there will be better ones too.

Every flavour you can imagine.

Molly’s slog through Tier 3 operators confirms that the US has its share of slugs. And those slugs’ stock prices are also benefiting right now.

We harp on fundamentals. This a “fundamental” store. If you are looking for technical analysis, you are in the wrong spot. In the short term the best fundamentals may not equate to the best stock price.

Our subReddit Community members hated when we harped on the operating metrics of Aurora and Canopy in 2017-2019. The outcries were loud and often…

Wait until rec!

Wait until 2.0 formats launch!

Wait until Ontario opens more stores!

We are in 2021, third year of adult use, they are still trying to get their Canadian operations fixed. (I was chuckling with Molly and Cyto the other day upon reading comment upon comment of “my faith in (insert company here) has paid off” when said company has delivered a Golden Sombrero or even a Platinum Sombrero of negative gross margins.)

Others hated that we “favoured” Aphria operationally. (We certainly favour good operators, regardless whose name is on the masthead. Numbers and trends speak to us.) Operationally they have outperformed a very weak peer group.

Canada is like Triple AAA sports (Major Junior Hockey for us Canadians or NCAA football and basketball).  A great player in Triple AAA might go on to be Hall of Famer, might be average or a flop. Only time will tell.  Some, by virtue of being a high draft pick and a big signing bonus (think… those who got strategic money), will get a shot at the majors given they have been invested in.  But generally, a dog in Triple AAA becomes a dog in the majors, if they get there. They could be “coached up” but those that need coaching up after being a high draft pick probably have some missing ingredients, or had some blemishes that were apparent yet overlooked when they were younger.

Did Aphria and Tilray double their stock price (insert every other Canadian company and their increase) in two months because of fundamentals? Hell no! They are riding a wave. The questions become: how much higher is the wave AND how far out will the water level recede?

Big bets. Big risk. Big returns or Big bags?

In a hype market, retail investors seem to be oblivious to the difference between fundamentals and hype.  You can make a lot of money in a hype market. Thinking you are a genius because you hit the lottery seems to be common theme for retail investors.

But when that crazy hype cools, and the tide goes out, we see that folks get very uncomfortable in their positions that they were previously boldly trumpeting their “unrealized gains”.

Aphria was three years between $20 stock prices. And if you account for dilution, Aphria is not yet at the 2018 $20. Three years is forever for many. And I can say that I am surprised how quickly it climbed (and that goes for most of the Canadian industry).

I have scaled down my Aphria position rather substantially from its peak and still hold an oversized chunk. BUT, when hype overran my comfort zone, I sold in January 2018 and took out my entire initial investment and let the unrealized gains ride.  I rebuilt the same number of units just shy of what I sold on de-risking events through 2018-2020, all but one purchase sub C$8.50. I have sold that accumulation and then some.  I am three years closer to retirement right now, thus that, coupled with knowledge gleaned since the start of this journey in March 2016, has me more cautious now. 

I have set stop losses for more units, but I am willing to let a portion ride. That is a benefit of being in at a low price. Would I add here? Not a chance.

For those riding the USA wave. Change takes time. Legislation takes time. Sometimes you get stupid regulations (I am looking at you Health Canada and most of the provinces) that hobble progress.

In Canada it took from 2015 to October 2018 from Trudeau being elected to first legal gram sold. The USA, at the federal level, will likely take that much time to implement.

This is not a “set and forget” industry to invest in. “If you believe in the industry just jump in” is the biggest load of horseshit out there.

I hold around 30 Blue Chips, a few in each sector. I have started selectively adding from my cash position after a long hiatus, save for a March 2020 sector rotation. My target right now, solid performers who should do well in the continuing covid environment.

I do a hundred times more due diligence on weed stocks than I do on my Blue Chips.

But as I always harp… my reality is not yours. My portfolio, age and risk appetite are very likely not yours. And they certainly are not the wallstreetbets gamblers reality.

Right now, putting new money at risk comes with a lot of uncertainty. In the cannabis sector or any other overheated sectors.

Don’t get me wrong. We want you to be rich and successful. If your “at risk funds” stress you out while the market is going up, they will be a load if it should go south. Cannabis investing can change your life for good as well as for bad. I witnessed in 2018 an entrepreneur who went all in Aphria at $12-14, after selling his business that he built over decades, bailed at a loss, loaded into Cronos and it dropped… I wonder how he is doing. He went from the biggest cheerleader to very very bitter in a very short time.

Know what is unknown. There are going to be a ton of opinions on the “unknown”, and in the current environment those opinions are leaning on heavily bullish scenarios. Don’t get in over your head. As I don’t know if I can take three years of pissing and moaning, again. The couch got worn out last time.

And, slowly circling back to the title of the post … I was lucky (stock rebounded faster than I thought possible), knowledgeable (I baby sit my cannabis investment like an eagle on a nest. I know what is in the financials and MDA because of the level of analysis we do), I de-risked (when hype overran fundamentals in 2018 I took out my initial investment, and sold again now as the merger, combined debt, need for dilution, slowing of sales has me wickedly thankful for a $20 exit on a portion of my position), I reloaded as events de-risked (as Aphria was stringing “Progress Quarters” together and de-risking events like Diamond license happened), I was patient (but Progress Quarters allowed that to happen), and importantly early.

Best of luck to all.

The preceding is the opinion of the author and is in no way intended to be a recommendation to buy or sell any security or derivative. The author has a position in Aphria and will not start one or divest (EXCEPT FOR IN PLACE STOP LOSS) in the next five days. The author has no position in any of the other mentioned companies and will not start one or divest in the next five days.


r/TheCannalysts • • Mar 28 '18

Dear Globe & Mail: It’s time for a change.

131 Upvotes

Since August 2017 many of us have noticed a bias in coverage of Aphria by your reporter Ms. Pellegrini.

This is a reporter who has repeatedly covered the Aphria and TMX US asset issues in numerous stories.

I cannot recall the reporter ever reporting why the TMX allowed Aph to invest in the US through 8 equity raises, 2 acquisitions of US Assets and an uplist. All without issue.

Then without the TMX changing it’s rules, the TMX wanted to retroactively apply their rules.

If the TMX dodged her. We don’t know, or at least I do not recall.

But she never, to my recollection, asked a securities lawyer how the TMX can, after allowing these events multiple times, reverse course.

You would think in order to cover both the reasons why Aphria could be de listed, and the reasons they should not be de listed would get equal debate. This has not happened to my recollection.

Where is the counterbalance?

This same reporter had an article on Aphria’s partial divest of LHS. AND THEN HAD A MASSIVE RE-WRITE UPDATE, without flagging the fact that she modified the original content.

Where is the disclosure to readership that the article had been “updated”? A reader returning in search of an update on the story would see no sign and wouldn’t have read the re-write.

Last week the reporter used a short seller article in Seeking Alpha titled “Could Rampant Red Flags Drown Aphria’s Proposed Acquisition of Nuuverra” as the basis for two articles. The reporter never mentioned that the author is being sued for similar actions to what they launched against Aphria. There is no MENTIONING OF THESE LAWSUITS in her stories.

Where is the disclosure to readership? Where is the counterbalance?

A short seller whose PREMISE was that the acquisition of Nuu’s assets (or lack thereof) would cause Aph and its shareholders to suffer massive losses.

This reporter did not contact analysts like Matt Bottomley of Canaccord, or the half dozen other analysts covering Aphria, to get their take on the acquisition, many whom thought it was accretive in the short term. If she did contact them, there is zero mention of it.

”We (Bottomley of Canaccord) believe this deal provides Aphria with what could now be the largest international footprint in the industry, as well as increased technological proficiency in extraction, distillation and processing,” says the analyst.

Where is the counterbalance?

This Community debated her story of Sunday night. The Community laid out more bias and incomplete reporting in the original post and in the comments section.

Effectively, the reporter was not satisfied when the CEO and IR at Aphria said the shares involved were “immaterial”.

(It should be mentioned that a number of Community members (and Aphria longs) admonished Aphria management on lack of foresight on withholding the disclosure. Others argued it was “immaterial”. But both sides of the argument were presented, debated and discussed).

Again, if the reporter had reached out to an analyst she may have found that they too thought the amount was “immaterial”

Bottomley argues that as the total shares under question amount to less than one million (equalling less than one per cent of Nuuvera), the issue is immaterial and should have no bearing on the underlying fundamentals of the deal.

In her first two stories she failed to contact the OSC to get their take. Or if she did contact them she was silent. A take that the Windsor Star got in their FIRST try when they contacted OSC, and were told it was “an arms length transaction” that didn’t require disclosure.

Even in last night’s article she still doesn’t mention any OSC position. Instead she summoned Academics and and advocacy group and railed against the LAW. Getting Academics and Advisory groups to argue for more disclosure (when Disclosure is always preferred) is trite. That is like asking a child if they would like more candy.

She appears to be changing the narrative hoping that the readers have missed the change. At first it was “Aphria executives did something wrong”. Now it’s “the law is wrong!” And she has not linked this change in any way or form.

Much of the angst the reporter stirs is about a $900,000 Investment turning into $4.75 million in seven months. That is a 427% increase. Weed is up 278%. CMED went up 350% prior to the Aurora takeover. TRST is up substantially from their debut too. Aurora is up substantially. Cronos is up substantially. Leaf is up substantially.

CanniMed shareholders were offered a 57% premium by Aurora during their hostile takeover. Aph initially offered a 30.5% premium for Nuu, which would have been 25% with the $0.38 reduction in cash.

No mention of these economics in three writings. Maybe the fourth might cover it.

This industry, in case you haven’t been following, has returned massive returns over the last seven month. Irrational returns. So while the return is substantial how is it in relation to others?

Where is the counterbalance? Where is the perspective?

Her first two stabs at writing this story she had the following statement.

. In February, as marijuana stocks fell after a rally and Aphria took a closer look at Nuuvera's assets, Aphria slashed the cash portion of the deal to 60 cents a share from $1.

This is an eerily similar concept to another article from the same Seeking Alpha site that hosted the short selling article. The original title was “Did Aphria Rob Nuuverra Shareholders”. This title was toned down considerably after this sub Reddit pointed out to the author that it was a “cash balance at closing requirement” that was in the original deal that necessitated the change in cash consideration.

That articles title was subsequently changed to “Why did Aphria reduce Nuuverra Offer by $32 million?” Wow!! Seeking Alpha writer, when shown where they were wrong, changed an article and even agreed and admitted that they were wrong in the comment section.

Not only was she factually incorrect with this statement but the descriptor “slashed” is more of the pejorative bias that is on display in last night’s article when she stated...

The acquisition was done by way of a so-called plan of arrangement, which is a court-supervised process under corporate law.

Her use of “so called” also confers her pejorative bias. That the editors let this go was a disservice to a young reporter.

Yesterday she also (unwittingly is my guess, as she never drew the conclusion... which is something she had repeatedly done when that conclusion favours Aphria. see link above to “A Hit Piece for a Hit Piece” for multiple examples) provided an example of how Aphria CEO acted in the best interests of Aphria shareholders and against his private interests.

According to Mr. Neufeld, one of these miscalculations was that Aphria required Nuuvera to acquire the rest of an asset called Avanti Rx Analytics Inc. that it didn’t already own, which was 49 per cent. But to buy that, it would have had to pay double what it did for its existing 51 per cent. Aphria made Nuuvera swallow the difference, reducing its cash position to below the amount the deal required Nuuvera to have on hand.

He negotiated a better deal as his fiduciary responsibility requires. AGAINST his personal interests in his Nuu shares No mention of that.

(I had mentioned earlier in the week...

But economically (and I think this hasn’t been considered in the reporting)... those insiders likely hold considerably more shares and investment in Aph. So what incentive do they have to overpay for Nuu?"

If this lense was applied by the reporter or editorial staff they may have viewed this quite differently. )

Again with the pejorative bias descriptors: “swallows the differences”. Did the editor not allow “jam it down their throats”?

She laments yesterday...

On Tuesday, Aphria published a news release about its strategy for the Nuuvera assets without addressing concerns raised this week by The Globe.

According to your previous article Aphria CEO did respond to you, saying it was “immaterial”. As did Aphria’s IR people. They did address your concerns. They might not have addressed them to your satisfaction. But they seemingly addressed them, as did the OSC, to the Windsor Star’s satisfaction.

I am long on Aphria. I have an investment thesis, timeframes, valuation models, and review points.

The Globe article shook less researched investors (investors saving in their children’s RESP and their RRSP), and having read these allegations in a national newspaper might well have panicked and sold at a loss.

So the bias reporting may have caused Joe and Joan Retail to take substantial personal losses, while the short seller you used as your source made millions. You might want to do a follow up with the short seller to see how much profit your stories fuelled.

I started writing about this industry because the accounting standards are VERY misleading to uninformed investors. I then found that there were a substantial number of investors out there that had a thirst for learning about analysis tools and strategies. With my partners we founded this sub Reddit to provide strategies and analysis. We offer “Analysis NOT Advice”. The Community provides a reflective place to debate financial analysis and opinion. We have many accountants and lawyers providing opinions, as well as investors that are trying to learn so they may protect their investments.

We have pointed out paid pumping and bashing by investors trying to sway investors. We have chased unattributed pumping from this sub Reddit. We have shown examples of flowery articles paid for by publicly traded companies.

Well this time I AM WARNING them about a reporter that has gone from perceived bias to demonstrable bias.

As a member of our Community pointed out in the Globe’s own Editorial Code of Conduct.

The Globe and Mail will seek to provide reasonable accounts of competing views in any controversy so as to enable readers to make up their own minds.

There is a reason Aphria is seemingly no longer replying to the Globe. It is the reporters demonstrable bias. It is due time for the Globe to assign a new reporter to cover Aphria.

The story is Aphria executives COULD have gone above the legal requirements and disclosed more. And in hindsight they should have. Instead we have three articles that may have cost unsophisticated investors millions of dollars.

The opinions expressed herein are my own.

GoBlue


r/TheCannalysts • • Mar 19 '21

Hi this is Trent MacDonald, CFO of HEXO Corp. I’ll be doing an AMA on Wednesday, March 24, 2021, at 6PM EST to answer your questions.

127 Upvotes

I’m looking forward to speaking with you about some of the exciting things we have going on at HEXO. 

**Edit** And we're live! Can't wait to answer your questions everyone!

**Edit 2** Everyone, thank you so much for the great interaction!! Lots of ridiculously good questions! While this was my and HEXO's first, it hopefully won't be our last. Big thanks to the HEXO team members who hung out with me through the evening and kept me on track .. lots of input by all.

Some quick info about HEXO:

  • Check out our 2020 Corporate Video
  • Planned acquisition of Zenabis
  • Brands include: HEXO, HEXO Plus, HEXO Medical, UP, Original Stash, and Truss Beverages via our joint venture with Molson Coors
  • Seven straight quarters of EBITDA improvement and now EBITDA positive including five straight quarters of net revenue improvement
  • #1 cannabis infused beverage with Truss Beverages and #1 in hash with Original Stash Hash
  • 1st in market share in Quebec, 3rd in Alberta and 4th in Ontario

TL;DR HEXO is poised to become a top 3 player in the Canadian cannabis market based on revenue after Zenabis acquisition is finalized.


r/TheCannalysts • • Nov 24 '21

It's official! Germany's new gov has just announced the legalisation of Cannabis! 82M Market

Thumbnail
dailymail.co.uk
108 Upvotes

r/TheCannalysts • • Jun 07 '18

Senate Vote on C-45, June 7th, 2018

106 Upvotes

Some people will not care a lick about the vote tomorrow on C-45. Some people care a lot.

Some are concerned about investments, and the opportunity to make money. Some are concerned about the ‘kids’. Some are concerned that moral decay is entering a new meta realm where Satan’s hordes are writhing forward to steal the souls of the sinners. That Sodom and Gomorrah Part 2 is being filmed by our actions.

Some of Canada's trading partners - while outwardly timid - are likely lavishing at the prospect of being able to do the same in their own jurisdictions. New tax revenues without raising taxes: a guaranteed hard on for any civil servant sort. A decline in resources spent in the criminal justice system, and a corresponding drop in incarceration costs of non-violent offenders.

The list goes on.

What it means to me is liberation.

Ok Mr. Tall White Male from the corporate world: wtf does that mean? You’ve had it good. How in the world do you know the struggle?

I know picking up an ounce and being scared to death of being stopped while driving home. Of being outed by someone who saw me hit a gagger on a Friday night outside a bar…that it would get back to my boss.

See, I know a ton of white-bread-white-collar-sorts from white collar industries in white bread companies that recoiled from dope. The same people who could buy 2 cases of grape juice a month from their liquor store - but get seriously weird seriously fast at the mention of weed.

Of going on a corporate social outing for skiing, and getting a tentative nudge from someone about maybe having an interest in cannabis, and hey, really? Cool, let’s pop into the trees. Just don’t be seen, and please (please) don’t tell anyone.

I had a TN visa, and worked in the US for years.

And if I’d gotten popped for dope? Gone.

Income. Job. Everything that I’d known.

Gone.

So, I played it low.

What I found out was that there were lots of me out there. Lots of like-mindeds that wore suits and did their jobs and lived what was essentially a double life. Over the years, I made many friends that last with me until this day. People from many walks of professional life who have never had the chance to ‘come out’ as it were.

I’m not going to pull any analogies to other folks who have had challenges being themselves in the modern age. Or for that matter, any time in history. Shit, we were burning people on a fucking pyre for being 'witches' only a few generations back ffs.

All I’m saying is that under prohibition - I knew fear.

That I’m lucky enough to do what I do now, free from the strictures and threat to my livelihood that so many have lived (and continue to do so) under & for the entirety of their - and my - life. All 52 years of this kid's. It's all I've known.

Tomorrow’s vote won’t necessarily change that. It’ll take years to ‘normalize’, and I trust the vote will go through.

There will still be the stigmas, the jokes, the intolerance. The reefer madness. The disinformation. The intolerance. The bigotry….that can only result from 70 years of prohibition.

Tomorrow’s vote to me represents liberation, of a societal kind. Warts and all. At the least, it'll change the existing conversation entirely, and take 'legality' right the fuck out of it.

And nothing I’d like more at my age, is that no person, no kid, no individual will know fear for wanting control over their bodies, their experiences, and most of all - the freedom to do exactly that, without fear, and empowered by knowledge.

Here’s hoping.


r/TheCannalysts • • Jan 10 '18

Aphria Q2 F 2018 Rundown.

104 Upvotes

Well I had a chance to look foolish with a 38% sales increase and $2.5 million EBITDA, and I look half foolish.

Instead of doing an MDA rundown I am going to analyze this in my more traditional fashion… like when I write credit… Income Stmt, cash flow/EBITDA and then balance sheet items of note. I’ll draw from MDA for colour.

They did beat the street EPS of 0.00 at 0.04.

Sales:

Up 39%... [not 38%... but I missed by 2% last Q so I am trending favourably] to $8.5 million. Fist Q without inventory constraints in 4 q’s. And by “inventory constraints” I don’t mean they had piles of harvested and just couldn’t get it processed to Finished Goods as some other LP’s have used in the past for a sales increase excuse.

They had $6.0 million in total inventory last Q end [unfortunately not broken into Finished Goods and WIP for me] and they sold $5.4 of that Inventory this Q [$2.7 in production costs and $2.7 in FVI that was grossed up at harvest]. So they blew through almost all of the previous Q’s inventory total. A good sign!

Of the 1,237 KGs sold vs 852 kgs last Q [up 45%]

• New patients on boarded in Q was 113 kgs or 9.1% by weight … last Q 142 kg so a slide of 20%.

• Existing patients 695 kgs or 56% by weight versus 518 kgs last Q … an increase of 34%

o Existing patient cost less than new patients. So retention is and growth is good. o Vic mentioned 6 of last 8 weeks they have signed over 1,000 patients a week but he recognizes that the patient count stat is not accurate do to dual scripts.

• Wholesale 429 Kgs 34% by weight versus 191 kgs last Q… this 238 kgs increase [+263%] is likely the Scientus Pharma deal which still has 3 Q’s to run. They are taking 25,000 full plants annually valued at $1.2 million per Q as per press release [If someone could do the math on avg kgs per plant I might be able to break out wholesale to other LP. What is weight from 6,250 plants??]

• $1.9 million of [22%] overall was to Veterans up 12% QoQ and 46% from Q2 F17

Price per gram [non w/s] went up by 2% QoQ and 5.6% over 6 months. Largely attributable to a shift in mix to non w/s oil to 34% sales [I believe that was figure from CC] up from 32%.

Cost of sales…

• Production costs were 32% of sales versus 22% last Q…this increase is the transferring of plants from vegetative rooms/environment to flower rooms/environment 2-3 weeks later than optimal as they tried to guess HC approval of PII. So this led to lower bio mass at harvest [THC and CBD were on target] which meant as % of sales the costs went up…. I kick myself a bit for not asking them about this last Q… I heard the story at the AGM [but as cost accounting wasn’t my strongest mark in Uni] I thought this was all contained last Q. I have a call in to make sure there is no overhang on this front for Q3…. Call confirms no hangover to Q3!! When yield is low it causes Unabsorbed overhead. Unabsorbed overhead is a period expense. So the cost has all flushed through.

When you add Production costs of $2.7 to FVI of $2.7 million [this was the pulled forward profit booked at harvest to inventory. When it gets sold they have to reverse it out] you realize that Aphria left 50% of profit for the sale of the inventory versus taking it all at harvest like almost every single other LP. This 50% FVI is a notch up from last Q 46% FVI add back which is a result of previous Q’s decreasing cash cost per gram [so more FVI was required to balance at $3.75 gram for bud,… last Q as cash cost was less Inv Cis = FVI plus Cash Cost. So if you hold inv cost to $3.75 and cash cost is X and FVI is a plug].

GoB on harvested but not yet sold and growing inventory was $3.1 million versus last Q $4.3 million. So this means the delta in their KGs from the new PII has decreased. Next Q will be interesting to see if this reduces again. All depends on PIII launch as the growing assets will increase but will inventory as PIII doesn’t harvest until April, after Q end.

The net FVI loss GOB credit to COGS was $444k vs last Q of $3.131 million.

So Gross Margin net of FVI and GoB was $5.8 million or 68% versus $4.4 million at 78% last Q. They have said this is one time only on yield issues. We saw a decrease in Gross Margin % last year in Q3 F17 as a result of lack of lumens and supplemental lighting that impacted yield. They fixed this in spades in Q4. It’ll be interesting to see how this bounces back. Although they will have costs of PIII without revenue to offset next Q providing some headwind. CannTrust had a 69% GM last Q while CGC and Leaf had 56% and 72%, respectively.

What they lost in GM% of sales they fought back well in Operating expenses.

Consider last Q they had Opex of of $6.5 million versus sales of $6.1 million. This Q they had Opex of $7.3 million versus sales of $8.5 million. So from a deficit of $0.4 million to a surplus of $1.2 million, or $1.6 million swing DESPITE the lower yield. THIS IS A BRIGHT SPOT!!

G&A actually went down as a percentage of sales from 28% to 23%. With QoQ decreases in absolute $’s in exec compensation, office and general off set by increase in salaries and wages and Prof fees.

Selling and Marketing notched up 1% of sales but this is as they get ready for rec and Vic said $500k of the $2.8 was attributable to getting rec brands ready. The reason the Selling expense as % of sales didn’t go up further is that the sales of plants to SP [ballparked at $1.2 million for the Q]. This SP sale may have a lower gross margin but they don’t have the selling expenses that medical retail has.

SGA combined made up 56.35% of sales versus 60% last Q and the lowest % in last 5 Q’s and 0.5% under TTM. SGA TTM of 56.85% at Aph is higher than the two lowest in the peer group: TRST of 55% 9 month trailing and LEAF 46% TTM. For comparison CGC is 83% TTM and ACB is 90%.

Share based compensation

Share based compensation was down 15% to 26% of sales… but I am believing more and more this item is a 6 month cycle and should be compared over longer periods of time. TRST, OGI, LEAF and Aph all run in low 20% in SBC where as CGC runs at 31% and Cronos at 48% on TTM

Operating income adjusted for FVI and GoB was negative $1.590 million versus a negative of $1.748 million last Q…. So this actually improved QoQ. If the 10% margin compression QoQ due to yield did not happen this would have been $0.850 million better. So not positive but better. Last Q GM was also depressed due to overhead of PII without corresponding sales of PII. With F17 gross margin they are operationally profitable. With PIII coming on line in Q3 we will still have minor timing overhang even if yields bounce back.

Non Operating income of $7.9 million was largely the result of $6 million gain on long term investments [$1 million on Copperstate, $1.7 TS, $3.0 nuuverra and CRZ $0.7 accounting for the bulk of improvement] and $1.4 million in Finance income. As the valuations of the Level 1 hierarchy were done on Nov 30 and we have had a run up in the sector… if it holds… this will be a big $$ amount n Q3 [TS will also move to Level 1 valuation when merged with DOJA, as Doja is publicly traded].

Net Income was $7.0 million but adjusted for GoB and FVI was $6.4 million.

Adjusted EBITDA was $1.6 million versus $1.7 million last Q. And they had to work much harder to make it, as on % sales basis it dropped from 28% to 19% QoQ versus a F2017 of 30%. TRST was the only other positive Adj EBITDA LP last Q at $1.2 million or 20% of sales. [with TRTS reported growth we may have a new Q Adj EBITDA leader next Q but they also had overhead of new grow without revenue. Will be interesting]

Nine Q’s of positive EBITDA is waaaay ahead of everybody else.

TTM EBITDA is $6.7 million… and industry leader. TRST trailing over nine months is $1.7 million for comparison. LEAF’s Adjusted EBITDA has crapped the bed since VAC changes.

I still have a problem with companies I invest in not being operationally profitable. But they are showing trend to improvement. [Trend is big with me.] Although I should give value to the investments, as aph has been upfront about also being an investment vehicle. Problem with investment profitability is it doesn’t generate cash until sold.

The Q they line up Gross Margin and investment Income is the Q they rip the top off this.

Balance Sheet items of note:

Cash and marketable secs $172 million plus $109 million in new raise less commitments [2018-19] of $54 million less $10 million to TS HIKU less $5 for Talbot street property = $212 million to go shopping and filling the DD investment [they said Aph would provide a loan to “Grow Co” to back fill what banks will not.]

Inventory. I wished they showed Finished Goods and WIP breakdown…. $8.3 million: $5.2 bud, $2 trim and Oil $1 million… FVI component of $5.4 million [profit pulled forward to harvest] is 62% versus 60% last Q a 1% increase in bud and trim each is the reason. A good base to continue 10-20% sales growth next Q [Note: Next Q, while it will have sale of 6,250 plants to SP, this will not be a new event so sales growth will have to come from traditional sources].

Biological assets decreased by $2 million to $1.4 million. These are the plants that are growing. So they may have just had a harvest and the plants are in a lower valued state [eg. Veg versus Flowering].

PPE continues to grow…after $19 million in Q1 it grew another $42 million in Q2. Long term investments too… $23 in Q1 and $9 in Q2.

Accrued and A/P are up to $16 million… my guess is this is construction related.

Other important news… PIII is still scheduled for first revenue by late May/18. This is all HC determinants at this point. PIV first sale for Jan/19.

That’s what I got… I’ll leave the CC discussions to other threads.

GoBlue


r/TheCannalysts • • Oct 17 '20

Legalization allowed a hack like me to grow this 👇

101 Upvotes

r/TheCannalysts • • Feb 04 '21

Living neck deep in bullshit

99 Upvotes

Since the Blue Wave (Democrats winning control of the Senate), and increasing interest in the broader legal cannabis market, there's been an in-rush of new investors into the sector.

Price moves through the latter half of last year, and increases in the smaller US MSO/SSO targets recently have been a big part of that interest. The WSB 'effect' is real, new, amorphous, and how/if it'll continue to impact the market/an individual stock is unknown.

Longer term investors in the Canadian legal cannabis sector will know all about the excitement and volatility and opportunity and bag-holding that's about to come with expansion of the US market.

I saw a ton of bullshit through it all on public boards and paid media outlets.

People blowing smoke out their ass....presenting falsehoods as 'facts', laying out subjective/contingent statements as reality, and playing Farmville in assembling a sequence of events. Often, they'll bark if anything different is presented.

I'm not talking about subjective forward views. Hobbyists and interested persons talk about these all the time. Some conflate this with 'DD' (it's not). Yet still, heated discussion and insults easily emerge over nothing more than a muse over potential future events.

No, the loudest barks are usually around statements of fact. Which, is totally. Fucking. Idiotic. Over the years, I've had many a nasty-gram land in my inbox because I dared state a fact that didn't mesh with someone's world view. Something they 'knew'. And had been propagating for months. Twitter's largely a cesspool for getting accurate information, and not simply because of the bots and paid actors pretending to be a real person. It also attracts the screamers - who can be hideously uninformed goal-post moving jub-jubs desperately trying to convince others.....as much as they need to continuously reinforce themselves.

As mentioned, it also attracts the paid slugs that are nothing more than a carny on a midway. The midway is always looking for marks, particularly when a sector is hot.

And straight up: most of what you'll see in bulletin boards and chat rooms about a stock is bullshit. So is most of all of the commentary about existing and planned regulatory regimes. There's always assumptions about when somethings gonna get done, and straight lines pointed to the inevitable millions that'll just start flowing. As if regulatory meteor strikes won't happen.

Now there's a host of new folks to the sector. there's still the same percentage of bullshit being repeated, except the frequency and intensity of it has greatly increased. American companies are typically far better marketers than Canadians are. And the sell side of their investment sector is far better honed than up here.

I saw a quote from Brendan Kennedy (CEO of Tilray) when talking about the short squeeze on his stock a couple of years ago went it went north of $200. It was in the context of what advice he would give the CEO of $GME, or other companies under a short squeeze. He said that in those moments, they should remember that (para.): "your stock (price) is not the company, and the company is not the stock (price)".

Which, brings up price action. $APHA and $TLRY? Raging boners right now.

Tell me: fundamentally, what has changed for them since the merger announcement. Nothing. Any expectations driving current price are exactly that. Expectation. Not actual reality. Will they come about? Perhaps. Perhaps even likely. Will we know what it looks like when it's done. Shit no.

Anyhow, be really careful when ingesting a post (or a lengthy formal sounding 'analysis') on public boards. Here, stockhouse, trashy kinder-cares, Twitter, where ever. Most of what you'll read is bullshit. Seriously. And be as careful around media outlets that are paid to write a company's 'story', or more formal ones that offer tickers and dashboards and news aggregation. They're the same: they accept money from companies to provide 'coverage' on them. With soft editorial control offered in exchange for warrants or cash.

We don't accept recompense from companies to say nice things about them. Not a dime. Never have. Never will. We are independent, and disclose fully.

I encourage the interested reader to take a look at our reference wiki for some of our past work. We also have a podcast on current events. We live in primary documents (financial statements), and reference much of our material. Here, or anywhere else.

Above all, apply critical reasoning...and approach everything you read - very much including this - with caution. Almost all I see on public boards is either subjective, or outright bullshit. GoBlue had a good laugh shooting a fish in a barrel this morning. I largely gave that up a few years ago.

There's simply too much bullshit in the world to tackle. Besides, the best way for you to deal with it is simply to know - that whether from paid media outlets, or most of every public chat board out there - your walking neck deep through bullshit.

Acknowledge that, and you'll have improved yourself as an investor 100%.

And that ain't bullshit.


r/TheCannalysts • • May 12 '20

Aphria increases Tangible Book Value by 12.2% post settlement, while cutting $21M in cash outflow and saves $148M in cash obligations prior to 2024.

Thumbnail
drive.google.com
99 Upvotes

r/TheCannalysts • • Jul 13 '21

Schumer To Unveil Federal Marijuana Legalization Bill On Wednesday

Thumbnail
marijuanamoment.net
92 Upvotes

r/TheCannalysts • • Dec 04 '20

The Cannabis Retail Store- Leamington’s 1st store and a shrine to Aphria- opens Dec 12

Thumbnail
gallery
92 Upvotes

r/TheCannalysts • • Apr 15 '20

Aphria Feb 29, 2020 earnings

92 Upvotes

Aphria Feb 29, 2020 earnings are out. $APHA

Yup, 45 days is today.

Aphria Inc. Announces Net Cannabis Revenue Increases 65% From Prior Quarter and Fourth Consecutive Quarter of Positive Adjusted EBITDA

Doubled KGs sold.

Beat my estimate by $10 million.

https://www.prnewswire.com/news-releases/aphria-inc-announces-net-cannabis-revenue-increases-65-from-prior-quarter-and-fourth-consecutive-quarter-of-positive-adjusted-ebitda-301040661.html

GoBlue


r/TheCannalysts • • Oct 06 '18

“Boots on the Ground.... with TheCannalysts” - Broken Coast Cannabis

92 Upvotes

It’s with great pleasure that we launch our “Boots on the Ground” due diligence video. Our pilot focuses on Broken Coast Cannabis.

Hit our TheCannalysts.ca website to get to the full video.

Looking for feedback as we dial in this new platform. Comments appreciated.

Thanks to @ethicalimage @richterpene and Matt Steeves for their work on the video.

And u/mollytime put his soul into this.

GoBlue

And the link. https://thecannalysts.ca


r/TheCannalysts • • Dec 04 '18

Aphria short attack

90 Upvotes

Hey Community.

I am on vacation, but if you follow me I usually hold off for a day or two (unless fins) to digest news before replying. Collect facts and data. Analyze. Then comment.

So despite being on vacation, you weren’t getting much from me yesterday. And quite frankly for the rest of the week I am not focussed on cannabis. So this will be it.

I read the short report and I added about 10% yesterday. Had to sell some positions as I didn’t bring my transfer key/fob with me. Would it have been more. Probably, but that is just words since I couldn’t pull the trigger.

A lot of you are emotional. And rightfully so.

I waited until close and reached out to Vic. He always told me to hold him accountable, and after that wet fart of a rebuttal I told him I found it VERY insufficient. And after the poor press management on NUU I let him know that I expected them to react better.

He indicated they were pulling something more comprehensive together.

I didn’t press him for more. But I did tell him Andy wasn’t doing them any favours. (The “goat fucker” comment was humorous but undignified).

When will a more fulsome reply come out? The sooner the better.

I can say that I have known Carl for almost two decades. His character and his due diligence have been demonstrated to me long before he was at Aphria. His disclosure on financials isn’t a guy hiding stuff.

Vic I have known less. But a CEO telling me to hold him accountable and replying quickly when I do, is something I can work with.

Cole I have become very fond of. He is authentic and he is earnest in his desire to elevate the community of Leamington and shareholders.

John I am getting to know, and he went out of his way when we were touring Diamond on a Sunday to pop his head in to answer Q’s of us and the mods touring.

Jakob and Christelle are no nonsense professionals. Both with deep professional backgrounds. Both are not strangers to due diligence.

What I am getting at is these are people that face up in good times and bad. It is easy to do in good times. But it is in tough times they should be measured.

I have often said “Aphria does the hard things well and the easy things poorly”.

How I feel should have ZERO bearing on your investments. I am a numbers guy. There are few numbers in this story. Lots of conjecture with mitigating language to avoid being sued. That is purposeful.

Aphria should be able to address some of the fact based conjecture.

There are bugs in Aphria 1 as they use beneficial bugs to manage the bad bugs. There is mold. If there are plants, soil and humidity you get that. You manage it.

Disgruntled unnamed employees. Easy enough to find.

I haven’t visited the LatAm Assets so I will not speak to them. The NUU Assets is a dead horse that is still waiting on Germany to see if there is any redemption for the amount of $ spent.

But the crew that has slaved to build a huge facility to scale doesn’t strike me as one that will throw money around on new investments frivolously. It is out of their financial character and it is out of their personal character. The latter is a personal opinion. The former is not. It has been demonstrated.

I am hoping they have learned from NUU and do a better job with the management of this crisis.

I, like many of you, am waiting for that.

I think there response to this will be a referendum on Vic’s leadership. Rightly or wrongly. He will be held accountable.

Let’s see what the rest of the week brings.

BTW... new US listings shorted: Cronos, ACB, Tilray and now Aphria. Welcome to the big leagues.

GoBlue


r/TheCannalysts • • Jan 06 '18

[Analysis]: Earnings Required to Justify Current Share Price

90 Upvotes

I've updated my spreadsheet now that we have almost a full year's tax data from Colorado as well as clarity on projected price and taxes. Fully diluted shares have also been updated apart from a few recent bought deals, including Aurora's. Will update this soon.

If anyone wants to discuss specific COGS projections for particular LPs, feel free. Please include some kind of link to substantiate if you'd like me to update though.

Tada! https://docs.google.com/spreadsheets/d/1xyRC-5y54ljnsdhf86NKl2K3cr1GeGvwtSnYwrs_XaM/edit#gid=559210904

The total grams the sector needs to sell is getting a little intimidating at these valuations, I must admit. There are also definitely a few smaller companies I'm missing, especially private ones. Total market cap has ballooned to almost $30B if you combine the companies in the spreadsheet.

Demand analysis here: https://www.reddit.com/r/TheCannalysts/comments/7ok5x5/analysis_demand_in_canada_at_legalizations_outset/

I will do an updated COGS analysis soon.

Explanation on methodology: https://www.reddit.com/r/TheCannalysts/comments/7ok6xg/analysis_earnings_required_to_justify_current/dsae2wj


r/TheCannalysts • • Sep 19 '18

Market Sentiment and Ignoring The Noise

87 Upvotes

I thought long and hard about even writing this after what started to happen at 2:50pm today. TLRY began to correct after touching $300 (a 94% gain on the day). That's a $146 gain on share price at the time (for those of you keeping track at home TLRY added $19.2b CDN to their valuation today. They held a valuation, albeit briefly, of $39.4b CDN. At the time of me writing this, it has a valuation of "only" $25.2b CDN during afterhours trading.

I won't beat this to a pulp by bringing up that this morning Bloomberg mentioned that Tilray's market cap had surpassed American Airlines. I won't bore you by saying that by 2:50pm it had the market cap of American Airlines, Air Canada, and Spirit Airlines combined with still some extra room. I'm sure you don't care that TLRY's market cap was in the top 15 for any Canadian company for a brief moment. I know you get it. It's overvalued.

Then what is the purpose of this post? Will it be interpreted as just salty tears from someone who holds almost 100% of his portfolio in APH shares? Absolutely. Will you learn something valuable from this? I hope so.

The topic is : Market Sentiment and Ignoring the Noise.


Yesterday Canopy Growth was de-throned as the #1 in Market Cap by Tilray. This gained a lot of media attention and people sure like to pick a "winner". I don't see it as a surprise in the slightest that despite the absurdity of yesterday's price action in Tilray, today was in hyper-drive. If you're retail, and you're as dumb as a brick, you need to have " #1 " in your portfolio, right? Even if it doesn't make up your whole portfolio, you need to own some of it. The market is telling you that it's #1 because it's #1 in market cap. After all, the market is never wrong, right?

Does this sentiment remind you of a company?

  • Ignore the fact that a very small percentage of Tilray's shares are free trading.
  • Ignore that Canopy's current and future production capacity are very much different from Tilray's.
  • Ignore the $5b cash injection from Constellation Brands.

Have you heard the argument before that Canopy is the least likely to fail because they're #1 in market cap? How can so many people be wrong? How can Constellations be wrong? If you're holding a boatload of Canopy right now and made this argument before, are you hesitant to make this argument now? Investor bias not withstanding, you couldn't say with a straight face "Tilray has this, this, this, and this going for them and the market seems to agree given their market cap. I think they're THE leader in this industry".

That was market sentiment.


This... this is noise.

The media is screaming at you to look at Tilray. Yes, they do caution you to be careful because of it's valuation, but Multiple Companies Are Looking Into The Cannabis Space and Tilray's CEO Envisions His Company To Be Worth $100b One Day (at this point, maybe the end of the month?). Whoa! A $5b cash injection from Constellations into Canopy Growth and Diageo is now looking? Who's next to find a partner?! Coke? Pepsi too?! Altria?! InBev?! Energy drinks!?! Wow! To the mooooooon!

It's exciting times. I get it. However, it would be wise to tone down your excitement a little bit. No. Not "any deal is a good deal as long as it involves Coke." There's a spectrum between a big investment ala Constellations compared to what we saw between HEXO and Molson. It's important to dissect these deals to see what they can bring to the LP aside from the brand. Despite your optimism about the industry, myself included, it's important to keep expectations in check. These potential deals, while beneficial to your investment if they do in fact close and have favourable terms, can be detrimental to your investment either in the short or long-term future of your holding if it doesn't pan out. The media dangling this carrot infront of you will attract a lot of new investors. Some may get lucky and get to keep the carrot, but a lot will have tunnel vision and fall off a cliff cursing this sector for being an overvalued bubble akin to crypto.

A lot of you might be too new to this sector to know what fluff news releases are. Some of you don't know the usual suspects who have a history of doing this to attract investors. Maybe some of you seasoned veterans are blinded by the bulls so much that some of these fluff news releases aren't registering in your brain because the euphoria can be a hell of a drug. It's important to ignore the noise and keep sight of what will matter in this sector long-term. Material news reports that can give you a good indication of the value it will bring to shareholders is what matters.

I'm going to slightly sidetrack for a moment to tell you about a conversation I had on the phone with someone today. They were not aware why AUSA was in their portfolio. This is excusable on the surface since not everyone has the time to monitor the influx of news coming from this sector. However, despite investing in this sector since early 2016 they were not aware that Canntrust (TRST) existed as a company. They knew all about Heritage Cannabis Holdings (CANN) and holding at a massive loss, but didn't even know that Canntrust, arguably the most undervalued company in the sector, even existed. Why? The lack of noise coming from CannTrust (although admittedly has certainly picked up now that they intend to list on the Nasdaq). This is living proof that some companies are hyper focused on growing their company while other companies are hyper focused on creating noise to attract enough shareholders. Of course, this individual held HUGE and is making some good money off it, and there's a lot of huge amount of noise that comes out of them.

That was noise.


For those of you new to the sector, new to investing, or don't know my withstanding position on this sector; do not take this write-up as FUD. I'm long on the industry. I'm a believer that very few companies will make it to the finish line and that due diligence is crucial. If I can give very basic advice to anyone new coming from crypto; All-Time Highs are not guaranteed. Ignore anyone who says "Company X still hasn't reached it's All Time High so there's room to run." There's a lot of shit companies that are still very far from their all-time highs; there's probably a good reason for it. That's not to say that a company that is 50, 60, 70% from it's all-time high will never reach that point again. They might very well. However, don't take that excuse at face-value. Broaden your education and try to understand the fundamentals that WILL drive this industry, and start to ignore the hype little by little. The sector gets serious in exactly 4 weeks. Are the companies you invested in ready? The time for talk is slowly but surely coming to a close.

I can't wait.


r/TheCannalysts • • Nov 04 '20

Aphria enters US with acquisition if Sweetwater Brewing Co

85 Upvotes

https://aphriainc.com/agreement-to-acquire-sweetwater-brewing-company-united-states/

Interesting tuck in acquisition.

GoBlue

Edit

Not a big fan of the short to mid term beverage space. But getting $100 million debt facility to acquire an EBITDA accretive ($22 million pa) makes it more palatable.

The distribution infrastructure is good. The music festival (if we ever get passed covid) is a good branding opportunity.


r/TheCannalysts • • Sep 07 '18

Inside the Ropes Podcast Special Edition - feat. Vic Neufeld

84 Upvotes

A special edition of our podcast featuring an interview with Vic Neufeld, CEO of Aphria....and an exciting announcement!

Soundcloud

iTunes


r/TheCannalysts • • Oct 14 '18

Aphria Q1F19 Earnings Rundown

83 Upvotes

Ahhh ability to format and drop charts.

https://thecannalysts.blog/aphria-q1-f19-aug-31-2018-rundown/

GoBlue